TA
Tim Anderson B of A Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Apogee Therapeutics
APGE
$2.21B
| $37.13 | $87 |
134%
upside
| Buy | 7 days ago |
|
|
MTSR
2
Metsera, Inc. Common Stock
MTSR
$3.81B
| $36.29 | $50 |
38%
upside
| Buy | 7 days ago |
|
3
Pfizer
PFE
$140B
| $24.54 | $28 |
14%
upside
| Neutral | 29 days ago |
|
4
Amgen
AMGN
$151B
| $280.10 | $261 |
7%
downside
| Underperform | 1 month ago |
|
5
Johnson & Johnson
JNJ
$431B
| $178.76 | $175 |
2%
downside
| Neutral | 1 month ago |
|
6
Regeneron Pharmaceuticals
REGN
$60.1B
| $567.22 | $547 |
4%
downside
| Underperform | 4 months ago |
|
7
Gilead Sciences
GILD
$140B
| $112.77 | $126 |
12%
upside
| Buy | 6 months ago |
|
8
AbbVie
ABBV
$376B
| $213 | $223 |
5%
upside
| Neutral | 6 months ago |
|
9
Moderna
MRNA
$9.45B
| $24.28 | $34 |
40%
upside
| Underperform | 6 months ago |
|
10
Merck
MRK
$210B
| $84.05 | $112 |
33%
upside
| Buy | 7 months ago |
|
11
Bristol-Myers Squibb
BMY
$95B
| $46.69 | $63 |
35%
upside
| Neutral | 8 months ago |
|
12
Biogen
BIIB
$20.5B
| $139.94 | $178 |
27%
upside
| Neutral | 8 months ago |
|
13
Eli Lilly
LLY
$666B
| $742.91 | $997 |
34%
upside
| Buy | 8 months ago |
|
|
14
Merck
MRK
$210B
| $84.05 | $127 |
51%
upside
| Outperform | 2 years ago |
|